Molecules · 2017 · 26 citations · 28 references
Natural SciencesBioengineeringMaterials ScienceBiocompatibilityBiomaterialsTissue EngineeringBioceramicsBone Tissue EngineeringImplant MaterialsImplantable BiomaterialsNanostructured BiomaterialsSynthetic Bone SubstitutesBiomaterial BiocompatibilityBiomaterial ImplantsBone Regeneration BiomaterialsBone Regeneration MaterialsHydroxyapatiteNanocomposite ImplantsPore StructureTissue Regeneration
In response to the demand for new implant materials characterized by high biocompatibility and bioresorption, two prototypes of fibrous nanocomposite implants for osseous tissue regeneration made of a newly developed blend of poly(l-lactide-co-glycolide) (PLGA) and syntheticpoly([R,S]-3-hydroxybutyrate), PLGA/PHB, have been developed and fabricated. Afibre-forming copolymer of glycolide and l-lactide (PLGA) was obtained by a unique method of synthesis carried out in blocksusing Zr(AcAc)4 as an initiator. The prototypes of the implants are composed of three layers of PLGA or PLGA/PHB, nonwoven fabrics with a pore structure designed to provide the best conditions for the cell proliferation. The bioactivity of the proposed implants has been imparted by introducing a hydroxyapatite material and IGF1, a growth factor. The developed prototypes of implants have been subjected to a set of in vitro and in vivobiocompatibility tests: in vitro cytotoxic effect, in vitro genotoxicity and systemic toxicity. Rabbitsshowed no signs of negative reactionafter implantation of the experimental implant prototypes.
28
Geometric Control of Cell Life and Death
Christopher S. Chen, Milan Mrksich, Sui Huang et al. · Science · 1997 · 4.7K citations
Donald E. Ingber, Judah Folkman · The Journal of Cell Biology · 1989 · 867 citations · Full text
Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells
Lingling Xian, Xiangwei Wu, Lijuan Pang et al. · Nature Medicine · 2012 · 634 citations · Full text